Genetics and regulation of angiopoietin-like proteins 3 and 4

Current Opinion in Lipidology

Volumn 17, Issue 2, 2006, Pages 152-156

  Li, Cai ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Fasting; Fuel partitioning; Lipoprotein; LPL; Nuclear hormone receptor

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANGIOPOIETIN; ANGIOPOIETIN LIKE PROTEIN 3; ANGIOPOIETIN LIKE PROTEIN 4; CELL NUCLEUS RECEPTOR; FATTY ACID; GW 0742; GW 1514; HORMONE RECEPTOR; LIPOPROTEIN LIPASE; LIVER X RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; ROSIGLITAZONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; IN VIVO STUDY; KNOCKOUT MOUSE; LIPOPROTEIN METABOLISM; LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; TRANSGENE;

ANGIOPOIETINS; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NUTRITION PHYSIOLOGY; NUTRITIONAL PHYSIOLOGICAL PHENOMENA;

EID: 33645529346     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mol.0000217896.67444.05     Document Type: Review

References (42)

1. Goldberg IJ, Merkel M. Lipoprotein lipase: physiology, biochemistry, and molecular biology. Front Biosci 2001; 6:388-405.
2. Merkel M, Eckel RH, Goldberg IJ. Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res 2002; 43:1997-2006.
3. Preiss-Landl K, Zimmermann R, Hammerle G, Zechner R. Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism. Curr Opin Lipidol 2002; 13:471-481.
4. Jensen DR, Schlaepfer IR, Morin CL, et al. Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase. Am J Physiol Regul Integr Comp Physiol 1997; 273 (2 Pt 2):683-689.
5. Babaev VR, Fazio S, Gleaves LA, et al. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J Clin Invest 1999; 103:1697-1705.
6. Ferreira LD, Pulawa LK, Jensen DR, Eckel RH. Overexpressing human lipoprotein lipase in mouse skeletal muscle is associated with insulin resistance. Diabetes 2001; 50:1064-1068.
7. Kim JK, Fillmore JJ, Chen Y, et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A 2001; 98:7522-7527.
8. Pulawa LK, Eckel RH. Overexpression of muscle lipoprotein lipase and insulin sensitivity. Curr Opin Clin Nutr Metab Care 2002; 5:569-574.
9. Ge H, Cha JY, Gopal H, et al. Differential regulation and properties of angiopoietin-like proteins 3 and 4. J Lipid Res 2005; 46:1484-1490. This study made a side-by-side comparison of Angptl3 and -4 on their assembly and regulation by feeding status and nuclear receptors.
10. Kersten S. Regulation of lipid metabolism via angiopoietin-like proteins. Biochem Soc Trans 2005; 33 (Pt 5):1059-1062.
11. Oike Y, Akao M, Kubota Y, Suda T. Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy. Trends Mol Med 2005; 11:473-479.
12. Koishi R, Ando Y, Ono M, et al. Angptl3 regulates lipid metabolism in mice. Nat Genet 2002; 30:151-157.
13. Shimizugawa T, Ono M, Shimamura M, et al. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem 2002; 277:33742-33748.
14. Shimamura M, Matsuda M, Kobayashi S, et al. Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes. Biochem Biophys Res Commun 2003; 301:604-609.
15. Inukai K, Nakashima Y, Watanabe M, et al. ANGPTL3 is increased in both insulin-deficient and -resistant diabetic states. Biochem Biophys Res Commun 2004; 317:1075-1079.
16. Kim I, Kim HG, Kim H, et al. Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem J 2000; 346 (Pt 3):603-610.
17. Kersten S, Mandard S, Tan NS, et al. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J Biol Chem 2000; 275:28488-28493.
18. Yoon JC, Chickering TW, Rosen ED, et al. Peroxisome proliferator- activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol Cell Biol 2000; 20:5343-5349.
19. Schmuth M, Haqq CM, Cairns WJ, et al. Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes. J Invest Dermatol 2004; 122:971-983.
20. Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004; 101:15718-15723. This study presented evidence on the role of intestine-derived Angptl4 in energy acquisition from food, utilizing Angptl4 knockout mice.
21. Wiesner G, Morash BA, Ur E, Wilkinson M. Food restriction regulates adipose-specific cytokines in pituitary gland but not in hypothalamus. J Endocrinol 2004; 180:1-6.
22. Belanger AJ, Lu H, Date T, et al. Hypoxia up-regulates expression of peroxisome proliferator-activated receptor gamma angiopoietin-related gene (PGAR) in cardiomyocytes: role of hypoxia inducible factor 1alpha. J Mol Cell Cardiol 2002; 34:765-774.
23. Ge H, Yang G, Huang L, et al. Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4. J Biol Chem 2004; 279:2038-2045. This provides evidence that Angptl4 is glycosylated and cleaved in vitro and in vivo.
24. Ono M, Shimizugawa T, Shimamura M, et al. Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo. J Biol Chem 2003; 278:41804-4189. This presents evidence that Angptl3 is cleaved in human plasma.
25. Xu A, Lam MC, Chan KW, et al. Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc Natl Acad Sci U S A 2005; 102:6086-6091. This study determined the induction of ANGPTL4 in humans by rosiglitazone and measured the plasma levels of ANGPTL4.
26. Ge H, Yang G, Yu X, et al. Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4. J Lipid Res 2004; 45:2071-2079. The authors determined the cysteine residues required for Angptl4 oligomerization and its importance for the potency of LPL inhibition by Angptl4.
27. Pajvani UB, Du X, Combs TP, et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 2003; 278:9073-9085.
28. Patel SD, Rajala MW, Rossetti L, et al. Disulfide-dependent multimeric assembly of resistin family hormones. Science 2004; 304:1154-1158.
29. Kaplan R, Zhang T, Hernandez M, et al. Regulation of the angiopoietin-like protein 3 gene by LXR. J Lipid Res 2003; 44:136-143.
30. Inaba T, Matsuda M, Shimamura M, et al. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor. J Biol Chem 2003; 278:21344-21351.
31. Shimamura M, Matsuda M, Ando Y, et al. Leptin and insulin down-regulate angiopoietin-like protein 3, a plasma triglyceride-increasing factor. Biochem Biophys Res Commun 2004; 322:1080-1085.
32. Le Jan S, Amy C, Cazes A, et al. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am J Pathol 2003; 162:1521-1528.
33. Yoshida K, Ono M, Koishi R, Furukawa H. Characterization of the 5′ regulatory region of the mouse angiopoietin-like protein 4. Vet Res Commun 2004; 28:299-305.
34. Mandard S, Zandbergen F, Tan NS, et al. The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J Biol Chem 2004; 279:34411-34420. This study demonstrated that ANGPTL4 is differentially processed in tissues and determined its plasma abundance in different human populations.
35. Akiyama TE, Lambert G, Nicol CJ, et al. Peroxisome proliferator-activated receptor β/δ regulates very low density lipoprotein production and catabolism in mice on a western diet. J Biol Chem 2004; 279:20874-20881.
36. Koster A, Chao YB, Mosior M, et al. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 2005; 146:4943-4950. This comprehensive study described the phenotypes of transgenic mice overexpressing Angptl4 from liver and mice with global knockout of Angptl3, -4, or both. It demonstrated direct interaction of Angptl4 and LPL.
37. Crawford PA, Gordon JI. Microbial regulation of intestinal radiosensitivity. Proc Natl Acad Sci U S A 2005; 102:13254-13259.
38. Yu X, Burgess SC, Ge H, et al. Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart. Proc Natl Acad Sci U S A 2005; 102:1767-1772. This was the first study to describe the autocrine/paracrine role of Angptl4 in tissues in an LPL-dependent manner.
39. Mandard S, Zandbergen F, van Straten E, et al. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 2006 (in press). This study demonstrated the role of Angptl4 over-expression in adipose tissue on accumulation of body fat.
40. Davis S, Papadopoulos N, Aldrich TH, et al. Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat Struct Biol 2003; 10:38-44.
41. Bergo M, Wu G, Ruge T, Olivecrona T. Downregulation of adipose tissue lipoprotein lipase during fasting requires that a gene, separate from the lipase gene, is switched on. J Biol Chem 2002; 277:11927-11932.
42. Wu G, Olivecrona G, Olivecrona T. The distribution of lipoprotein lipase in rat adipose tissue. Changes with nutritional state engage the extracellular enzyme. J Biol Chem 2003; 278:11925-11930.